Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableLooking for participantsNCT04220970
What this trial is testing

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Who this might be right for
Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation 150
Not applicableUnknownNCT05017337
What this trial is testing

Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular Contracture

Who this might be right for
Breast Implant-Associated Anaplastic Large Cell LymphomaCapsular Contracture, ImplantBreast Implant; Complications
Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85